Showing 51-60 of 360 results for "".
- AestheticWires’s Toxin Pipeline Watch: RelabotulinumtoxinA Smoothes Crow’s Feet and Frown Lines Quickly and Results Last in Phase IIIb Studieshttps://modernaesthetics.com/news/aestheticwiress-toxin-pipeline-watch-relabotulinumtoxina-smoothes-crows-feet-and-frown-lines-quickly-and-results-last-in-phase-iiib-studies/2473537/RelabotulinumtoxinA produces rapid and long-lasting effects on crow’s feet and frown kines, according to topline results from two phase IIIb studies. Galderma’s relabotulinumtoxinA is a novel liquid formulation of botulinum toxin A currently being investigated globally.
- Exosome X Mitochondrial Technology: Elevai Labs Enters Into Licensing Agreement With Yuva Bioscienceshttps://modernaesthetics.com/news/exosome-x-mitochondrial-technologies-elevai-labs-enters-into-licensing-agreement-with-yuva-biosciences/2473536/Elevai Labs, Inc. signed a licensing agreement with Yuva Biosciences, Inc. to research and develop means to incorporate Yuva Bioscience’s mitochondrial research with ELEVAI’s PREx (Precision Regenerative Exosome Technology) in topical skincare. The potential collab could com
- Modern Aesthetics® Named Exclusive Media Partner for Octane’s Aesthetics Tech Forum for Second Year in a Rowhttps://modernaesthetics.com/news/modern-aesthetics-named-exclusive-media-partner-for-octanes-aesthetics-tech-forum-for-second-year-in-a-row/2473520/Modern Aesthetics® magazine is the exclusive media partner for Octane’s Aesthetics Tech Forum for the second consecutive year. This year’s Forum will take place at the Balboa Bay Resort in Newport Beach, Calif. January 25-26, 2024.
- Sentient Adds to C-Suitehttps://modernaesthetics.com/news/sentient-adds-to-c-suite/2473510/Brian Kirk is Sentient’s new Chief Marketing Officer (CMO), and Jennifer Redmond joins as Chief Revenue Officer (CRO). Mr. Kirk is charged with elevating Sentient's marketing investment to support Tixel by Sentient and Sentient Sculpt, wh
- Hair Relaxers Linked to Uterine Cancer in Black Womenhttps://modernaesthetics.com/news/hair-relaxers-linked-to-uterine-cancer-in-black-women/2473506/Long-term use of chemical hair relaxers by postmenopausal Black women may increase risk of uterine cancer, according to a new study by researchers at Boston University’s Black Women’s Health Study (BWHS). These products contain potentially harmful ingredients, including chem
- FDA Grants 510(k) Clearance to Venus the Versa Pro Systemhttps://modernaesthetics.com/news/fda-grants-510k-clearance-to-venus-the-versa-pro-system/2473495/The U.S. Food and Drug Administration has granted marketing clearance to Venus Concept Inc.’s Venus Versa Pro System. Venus Versa is customizable and upgradable and supports 10 optional applicators which utilize Venus Concept’s (MP)2, IPL and NanoFractional RF tec
- Cutera, Inc. Appoints Jeff Jones as Chief Operating Officerhttps://modernaesthetics.com/news/cutera-inc-appoints-jeff-jones-as-chief-operating-officer/2473482/Jeff Jones is Cutera, Inc.’s new Chief Operating Officer, effective August 28, 2023. Mr. Jones will report directly to Taylor Harris, Cutera’s Chief Executive Officer, and will be responsible for end-to-end operations, including manufacturing, quality, supply chain, fi
- Calling all Applicants: Estée Lauder Companies New Incubation Ventures Launches 2023 BEAUTY&YOU India Programhttps://modernaesthetics.com/news/calling-all-applicants-estee-lauder-companies-new-incubation-ventures-launches-2023-beautyyou-india-program/2473469/The Estée Lauder Companies (ELC) is launching the second edition of BEAUTY&YOU. Created by ELC’s New Incubation Ventures and launched in partnership with India’s preferred beauty and lifestyle retailer, NYKAA, BEAUTY&YOU aims to continue its mission to di
- Estée Lauder, Manchester United Partner to Boost Fans’ Skin Healthhttps://modernaesthetics.com/news/estee-lauder-manchester-united-partner-to-boost-fans-skin-health/2473451/Estée Lauder will team up with Manchester United, to reach and engage their extensive fanbase in China and the Asia Pacific region. Kicking off in Summer 2023, the partnership’s inaugural campaign will launch with players from Manchester United’s first team, inc
- LASEROPTEK Co. Ltd. Taps Dr. Neil Shah as New KOLhttps://modernaesthetics.com/news/laseroptek-co-ltd-taps-dr-neil-shah-as-new-kol/2473433/Neil Shah, MD, is now a national key opinion leader (KOL) for LASEROPTEK's PALLAS UVB laser system for inflammatory skin conditions. LASEROPTEK's PALLAS laser system is a UVB laser that is US Food and Drug Administration (FDA) -cleared to treat inflammatory skin condit